Clinical Trials Logo

Paracentesis clinical trials

View clinical trials related to Paracentesis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05964439 Recruiting - Paracentesis Clinical Trials

Augmented Reality Ultrasound Guidance

HoloUS
Start date: March 11, 2022
Phase: N/A
Study type: Interventional

Many medical procedures are done with the aid of ultrasound imaging, but they remain difficult to learn and perform. This study will use augmented reality technology for making these procedures potentially more intuitive, easier, more precise, and safer.

NCT ID: NCT04322201 Recruiting - Critical Illness Clinical Trials

Continuous Passive Paracentesis for Intra-abdominal Hypertension

COPPTRIAHL
Start date: November 2, 2019
Phase: N/A
Study type: Interventional

Liver cirrhosis patients in Intensive Care present intra-abdominal hypertension and this is an independent risk factor for increased organ disfunction and mortality. Patients will be randomized into intermittent or continuous passive paracentesis and the clinical results of these two strategies for preventing and treating intra-abdominal hypertension will compared.

NCT ID: NCT03506893 Recruiting - Cirrhosis Clinical Trials

Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

ARIAPUMP
Start date: July 17, 2018
Phase: N/A
Study type: Interventional

The hypothesis is that the Alfapump® strategy would be more effective in terms of QALYs generated , and that the cost of Alfapump® device and its implantation will be totally or partially offset by the reduction in the number of evacuating parentheses performed and the reduction in the number of complications in patients with refractory ascites awaiting liver transplantation or not. On the other hand, given the difference in the clinical profiles of these two populations (whether or not they are awaiting transplantation), these two populations will be study separately Evaluation of the medical-economic impact at 1 year of the two therapeutic strategies: implantation of Alfapump® versus repeated evacuating paracentesis in cirrhotic patients with refractory ascites without scheduled liver transplantation.